HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 781-792 of 4,505
Drug study icon
Recruitment unclearEUCTR 2013-005399-16

Randomized, flexible-dose, open-label comparison to investigate the effectivenes of second generation antipsychotics in first episode psychosis patients.

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In Spain
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Dr. Benedicto Crespo. Servicio Psiquiatría. Hospital Universitario Marqués de Valdecilla/IDIVAL
Drug study icon
CompletedNCT00357006

A Definitive Estrogen Patch Study (ADEPT)

Official study title

Multisite Double-Blind Randomized Controlled Study of Estradiol Plus Antipsychotic Versus Placebo Plus Antipsychotic in the Treatment of Psychotic Symptoms in Women With Schizophrenia

This study has finished and is no longer accepting participants.

In Melbourne
Schizophrenia, BipolarityMedication studyAges 18–50
Countries
Australia
Sponsor
The Alfred
Drug study icon
CompletedNCT01855074

Risperidone Long-Acting Microspheres for schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of Risperidone for people with schizophrenia.

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaMedication studyAges 18+
Countries
Sponsor
Janssen-Cilag Ltd.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.